|
THE SENATE |
S.B. NO. |
1393 |
|
THIRTY-SECOND LEGISLATURE, 2023 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO METHADONE TREATMENT PROGRAMS.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
"(b) Registration of a methadone treatment program requires that:
(1) The methadone treatment program obtain a controlled substance registration from the State of Hawaii and the Drug Enforcement Administration;
(2) The medical director of a methadone treatment program obtain a controlled substance registration from the State of Hawaii and the Drug Enforcement Administration at the location of the program;
(3) Admission to a methadone treatment program be limited to the narcotic-dependent persons as defined in this chapter;
(4) Unless otherwise stated in this chapter, admission to a methadone treatment program be in accordance with Title 21 Code of Federal Regulations Part 291 and Title 42 Code of Federal Regulations Part 8;
(5) All medical orders including initial medication orders, all subsequent medication order changes, all changes in the frequency of take-home medication, and the prescription of additional take-home medication for emergency situations be authorized by a licensed registered physician employed by the program;
(6) Only the medical director or other designated program physician authorize a patient's admission for treatment in accordance with Title 21 Code of Federal Regulations Part 291 and Title 42 Code of Federal Regulations Part 8; and
(7) Take-home doses of methadone be
dispensed to patients in accordance with Title 21 Code of Federal Regulations
Part 291 and Title 42 Code of Federal Regulations Part 8, but shall not exceed [a
fourteen-day supply] the maximum days of supply allowable under federal
law at any given time nor more than the maximum amount of take-homes for
Levo-alphacetylmethadol (LAAM/Orlamm) that would allow a patient to be away
from the clinic for dosing for more than two weeks unless authorized by the state
authority.
The term "methadone treatment program" as used in this section means an organization or a person (including a private physician) that administers or dispenses methadone to a narcotic-dependent person for maintenance or detoxification treatment and who provides the medical and rehabilitative services required by Title 21 Code of Federal Regulations Part 291 or Title 42 Code of Federal Regulations Part 8 and is approved to do so by the State and by the United States Substance Abuse and Mental Health Services Administration, and who holds a controlled substance registration as required by this chapter and the United States Drug Enforcement Administration to use methadone for the treatment of narcotic-dependent persons.
The term "narcotic-dependent person" as used in this section means an individual who physiologically needs heroin or a morphine-like drug to prevent the onset of signs of withdrawal.
The
term "state authority" as used in this section means the agency
within the State [which] that exercises the responsibility for
governing the treatment of narcotic-dependent persons with the narcotic drug
methadone."
SECTION 2.
Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 3. This Act shall take effect upon its approval.
|
INTRODUCED BY: |
_____________________________ |
|
|
BY REQUEST |
Report Title:
Methadone Treatment Programs; Maximum Supply Limits
Description:
Amends section 329-40, Hawaii Revised Statutes (HRS), to allow the medical director of a methadone treatment program to dispense the maximum days of supply of take-home doses as allowed under federal law to a patient.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.